Aditya Tolia

Private Equity Senior Analyst·OrbiMed

Mumbai, Maharashtra, India

Bio

Professional summary

Aditya Tolia is listed as a Private Equity Senior Analyst at OrbiMed in Mumbai, having joined the firm in May 2022. His prior experience includes investment banking roles at Investec and PwC. His public profile lists finance, financial modeling, M&A and private equity among his skills.

Background

Career, education, and skills

Career history

OrbiMedPrivate Equity Senior Analyst2022 – Present
InvestecInvestment Banker2021 – 2022
PwCSenior Analyst, Investment Banking2018 – 2020
PwCIntern, Data Analytics2017 – 2017
JM Financial LtdIntern, Investments2016 – 2016
Kotak Mahindra BankIntern, Industry Research Division2015 – 2015

Education

The University of ManchesterBachelor of Arts2015-2018

Skills

FinanceFinancial ModelingMergers & Acquisitions (M&A)Private EquityFDDMicrosoft ExcelMicrosoft PowerPointResearch

Other partners at OrbiMed

12 more profiles

View firm →

Alexis Megibow

Private Equity Associate

OrbiMed

Private Equity Associate at OrbiMed.

Healthcare investingPrivate equityVenture capital

Ankesh Bhansali

Managing Director

OrbiMed

OrbiMed Asia Managing Director focused on healthcare private equity.

Asia healthcareCapital marketsHealthcare deliveryHealthcare private equityM&APharmaceuticals

Arun Sadhanandham

Managing Director

OrbiMed

OrbiMed Asia Managing Director investing in healthcare private equity.

Asia healthcareHealthcare deliveryHealthcare private equityInvestment bankingMedical devicesPharmaceuticals

Brendan Weber, CFA

Principal

OrbiMed

Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.

Healthcare creditMedical devicesPharmaceuticalsRoyalty-based financingStructured credit

Carl Gordon

Managing Partner

OrbiMed

OrbiMed Managing Partner leading private equity and biotech company formation.

BiotechnologyBoard governanceCompany formationHealthcare private equityInnovative therapeuticsLife sciences

Carl L. Gordon

Managing Partner

OrbiMed

Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.

Life-sciences private equityTherapeuticsVenture investing

Carter Neild

Managing Partner

OrbiMed

OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.

Asia private investmentsHealthcare private equityHealthcare royaltiesInvestment managementStructured healthcare finance

Clay Daniel DeMarcus

Principal

OrbiMed

Principal focused on medical technology and non-therapeutics venture investing.

Healthcare equity researchHealthcare investment bankingMedical technologyNon-therapeuticsVenture-stage investing

Cooper Steputis

Private Equity / Venture Capital

OrbiMed

Healthcare private equity and venture investor with prior investment banking experience.

Healthcare venture capitalInvestment bankingMolecular biologyNeurosciencePrivate equity

Daniel Ying

Executive Director

OrbiMed

OrbiMed Asia Executive Director focused on pharma and biotech investments.

Asia healthcareBiotechnologyChina healthcare marketHealthcare private equityPharmaceuticals

David Bonita

General Partner

OrbiMed

OrbiMed General Partner and physician-investor in healthcare and therapeutics.

BiotechnologyBoard governanceHealthcare investingMedical devicesOncologyTherapeutics

David Wang

Partner

OrbiMed

OrbiMed Asia Partner focused on Greater China healthcare investments.

BiotechnologyDiagnostic imagingGreater China healthcareHealthcare private equityMedical diagnosticsPersonalized medicine

See something out of date?

Suggest a correction — our team reviews every edit.

Improve this profile